LoginDr. Livesay’s presentation will cover sources of testing variability, case studies of actual state regulations, and brief comparative analysis of currently available analytical options that draws heavily from peer-reviewed scientific literature, including recently published reviews of cannabinoid analytical technologies. Dr. Livesay will emphasize the necessity and superiority of non-destructive analytical technologies for in-house use of cannabinoid testing.
